Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 8 (2011), Issue 7 (July)

1. Impact of anastomotic techniques on airway complications after lung transplant.
   Ann Thorac Surg, 92(1): 316-20; discussion 320-1. [Abstract] [Full-text]
2. Lung transplantation and coronary artery disease.
   Ann Thorac Surg, 92(1): 303-8. [Abstract] [Full-text]
3. Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery.
   Ann Thorac Surg, 92(1): e1-3. [Abstract] [Full-text]
4. Positive virtual crossmatch with negative flow crossmatch results in two cases.
   Transpl Immunol, 25(1): 77-81. [Abstract] [Full-text]
5. Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?
   Transpl Immunol, 25(1): 27-33. [Abstract] [Full-text]
6. A polymorphism of NADPH oxidase p22 phox is associated with reduced susceptibility to acute rejection in renal allograft recipients.
   Transpl Immunol, 25(1): 16-9. [Abstract] [Full-text]
7. Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.
   Transpl Immunol, 25(1): 56-60. [Abstract] [Full-text]
8. Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation.
   Transpl Immunol, 25(1): 1-6. [Abstract] [Full-text]
9. Donor or recipient TNF-A -308G/A polymorphism and acute rejection of renal allograft: A meta-analysis.
   Transpl Immunol, 25(1): 61-71. [Abstract] [Full-text]
10. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006.
    J Clin Microbiol, 49(7): 2404-10. [Abstract] [Full-text]
11. Outcomes after heart transplantation in children under six years of age.
    Ann Thorac Surg, 92(1): 174-82. [Abstract] [Full-text]
12. Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
    J Clin Microbiol, 49(7): 2743-7. [Abstract] [Full-text]
13. Adenovirus-mediated anti-sense ERK2 gene therapy inhibits tubular epithelial-mesenchymal transition and ameliorates renal allograft fibrosis.
    Transpl Immunol, 25(1): 34-41. [Abstract] [Full-text]
14. Macrophages and T lymphocytes are the predominant cells in intimal arteritis of resected renal allografts undergoing acute rejection.
    Transpl Immunol, 25(1): 42-8. [Abstract] [Full-text]
15. A modified splint tubing technique for heterotopic heart transplantation in mouse.
    Transpl Immunol, 25(1): 82-7. [Abstract] [Full-text]
16. Reduction in airway complications after lung transplantation with novel anastomotic technique.
    Ann Thorac Surg, 92(1): 309-15. [Abstract] [Full-text]
17. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
    Transpl Immunol, 25(1): 72-6. [Abstract] [Full-text]
18. De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients.
    BJU Int, 108(2): 229-34. [Abstract] [Full-text]
19. Performance of the Roche Total Mycophenolic Acid® assay on the Cobas Integra 400®, Cobas 6000® and comparison to LC-MS/MS in liver transplant patients.
    Clin Chem Lab Med, 49(7): 1159-65. [Abstract] [Full-text]
20. Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation.
    Cell Immunol, 270(1): 5-12. [Abstract] [Full-text]
21. Diagnostic efficiency of truncated area under the curve from 0 to 2 h (AUC₀₋₂) of mycophenolic acid in kidney transplant recipients receiving mycophenolate mofetil and concomitant tacrolimus.
    Clin Chem Lab Med, 49(7): 1167-70. [Abstract] [Full-text]
22. Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: a preliminary study involving rabbit models.
    Injury, 42(8): 782-9. [Abstract] [Full-text]
23. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium.
    Chest, 140(1): 221-9. [Abstract] [Full-text]
24. Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.
    J Immunol, 187(2): 1023-30. [Abstract] [Full-text]
25. Cardiovascular risk assessment of the liver transplant candidate.
    J Am Coll Cardiol, 58(3): 223-31. [Abstract] [Full-text]
26. Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.
    J Am Soc Nephrol, 22(7): 1375-81. [Abstract] [Full-text]
27. Low incidence of urinary tract infections following renal transplantation in children with bladder augmentation.
    J Urol, 186(2): 667-71. [Abstract] [Full-text]
28. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Transplantation, 92(2): 217-23. [Abstract] [Full-text]
29. Alcohol consumption, new onset of diabetes after transplantation, and all-cause mortality in renal transplant recipients.
    Transplantation, 92(2): 203-9. [Abstract] [Full-text]
30. Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
    Transplantation, 92(2): 235-43. [Abstract] [Full-text]
31. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient.
    Transplantation, 92(2): 163-9. [Abstract] [Full-text]
32. Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience.
    Transplantation, 92(2): 210-6. [Abstract] [Full-text]
33. Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome.
    Transplantation, 92(2): 176-82. [Abstract] [Full-text]
34. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients.
    Transplantation, 92(2): 224-9. [Abstract] [Full-text]
35. Dialysis and transplantation among Aboriginal children with kidney failure.
    CMAJ, 183(10): E665-72. [Abstract] [Full-text]
36. Prophylactic peritoneal fenestration to prevent morbidity after kidney transplantation: a randomized study.
    Transplantation, 92(2): 196-202. [Abstract] [Full-text]
37. Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation.
    Transplantation, 92(2): 190-5. [Abstract] [Full-text]
38. Type I interferon pathway mediates renal ischemia/reperfusion injury.
    Transplantation, 92(2): 131-8. [Abstract] [Full-text]
39. Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study.
    Transplantation, 92(2): 230-4. [Abstract] [Full-text]
40. Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
    Transplantation, 92(2): 183-9. [Abstract] [Full-text]
41. Pathophysiologic significance of B-cell clusters in chronically rejected grafts.
    Transplantation, 92(2): 121-6. [Abstract] [Full-text]
42. Intrarenal IFN-γ mRNA expression differentiates clinical and subclinical glomerulitis in renal transplant recipients.
    Transplantation, 92(2): 170-5. [Abstract] [Full-text]
43. Diazoxide suppresses hepatic ischemia/reperfusion injury after mouse liver transplantation by a BCL-2-dependent mechanism.
    J Surg Res, 169(2): e155-66. [Abstract] [Full-text]
44. Chronotropic responses to exercise in heart transplant recipients: 1-yr follow-up.
    Am J Phys Med Rehabil, 90(7): 579-88. [Abstract] [Full-text]
45. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.
    J Am Acad Dermatol, 65(2): 263-79; quiz 280. [Abstract] [Full-text]
46. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
    J Am Acad Dermatol, 65(2): 253-61; quiz 262. [Abstract] [Full-text]
47. Impact of food and herbal medication on calcineurin inhibitor dose in renal transplant patients: a cross-sectional study.
    J Med Food, 14(7): 756-60. [Abstract] [Full-text]
48. Lung transplantation.
    Am J Respir Crit Care Med, 184(2): 159-71. [Abstract] [Full-text]
49. Preliminary results after reconstruction of bony defects of the proximal humerus with an allograft-resurfacing composite.
    J Bone Joint Surg Br, 93(8): 1098-103. [Abstract] [Full-text]
50. Impaction bone grafting: a laboratory comparison of two methods.
    J Bone Joint Surg Br, 93(8): 1049-53. [Abstract] [Full-text]
51. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis.
    Arch Dermatol, 147(7): 790-6. [Abstract] [Full-text]
52. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases.
    Arch Surg, 146(7): 859-64. [Abstract] [Full-text]
53. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Arch Surg, 146(7): 824-9. [Abstract] [Full-text]
54. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type.
    Arch Surg, 146(7): 778-84. [Abstract] [Full-text]
55. Biomarkers in solid organ transplantation.
    Clin Pharmacol Ther, 90(2): 217-20. [Abstract] [Full-text]
56. Ethical considerations regarding disparities pertaining to kidney transplant patients.
    Clin Pharmacol Ther, 90(2): 212-4. [Abstract] [Full-text]
57. Full face transplant: the first case report.
    Ann Surg, 254(2): 252-6. [Abstract] [Full-text]
58. Humanized mice with ectopic artificial liver tissues.
    Proc Natl Acad Sci U S A, 108(29): 11842-7. [Abstract] [Full-text]
59. Diffusion-weighted MRI of the transplanted liver.
    Clin Radiol, 66(9): 820-5. [Abstract] [Full-text]
60. Proliferative glomerulonephritis with monoclonal IgG deposits recurs or may develop de novo in kidney allografts.
    Am J Kidney Dis, 58(2): 276-81. [Abstract] [Full-text]
61. Noninvasive and direct measures of kidney size in kidney donors.
    Am J Kidney Dis, 58(2): 266-71. [Abstract] [Full-text]
62. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Laryngoscope, 121(8): 1718-25. [Abstract] [Full-text]
63. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.
    Transplantation, 92(3): 303-10. [Abstract] [Full-text]
64. Infantile choriocarcinoma in a neonate with massive liver involvement cured with chemotherapy and liver transplant.
    J Pediatr Hematol Oncol, 33(6): e258-60. [Abstract] [Full-text]
65. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation.
    Electrophoresis, 32(15): 2063-70. [Abstract] [Full-text]
66. Comparison of open and laparoscopic live donor left lateral sectionectomy.
    Br J Surg, 98(9): 1302-8. [Abstract] [Full-text]
67. Addition of a water-soluble propofol formulation to preservation solution in experimental kidney transplantation.
    Transplantation, 92(3): 296-302. [Abstract] [Full-text]
68. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients.
    Transplantation, 92(3): 346-50. [Abstract] [Full-text]
69. Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats.
    Transplantation, 92(3): 271-9. [Abstract] [Full-text]
70. Improved rejection prophylaxis with an initially intensified dosing regimen of enteric-coated mycophenolate sodium in de novo renal transplant recipients.
    Transplantation, 92(3): 321-7. [Abstract] [Full-text]
71. Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports.
    Transplantation, 92(3): 316-20. [Abstract] [Full-text]
72. When the law meets organ transplantation: the experience from the United kingdom.
    Transplantation, 92(3): 262-4. [Abstract] [Full-text]
73. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
    Transplantation, 92(3): 328-33. [Abstract] [Full-text]
74. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
    Transplantation, 92(3): 289-95. [Abstract] [Full-text]
75. Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vesicoureteral reflux to the graft.
    Transplantation, 92(3): 311-5. [Abstract] [Full-text]
76. Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study.
    Transplantation, 92(3): 334-40. [Abstract] [Full-text]
77. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Transplantation, 92(3): 267-70. [Abstract] [Full-text]
78. Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
    Transplantation, 92(3): 341-5. [Abstract] [Full-text]
79. Preservation of kidneys from controlled donors after cardiac death.
    Br J Surg, 98(9): 1260-6. [Abstract] [Full-text]
80. Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.
    Br J Surg, 98(9): 1201-8. [Abstract] [Full-text]
81. Immunosuppression: does one regimen fit all?
    Transplantation, 92(3): 251-61. [Abstract] [Full-text]
82. Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.
    Hepatology, 54(2): 418-24. [Abstract] [Full-text]
83. Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies.
    Hepatology, 54(2): 541-54. [Abstract] [Full-text]
84. Desensitization in HLA-incompatible kidney recipients and survival.
    N Engl J Med, 365(4): 318-26. [Abstract] [Full-text]
85. Post liver transplantation acute kidney injury in a rat model of syngeneic orthotopic liver transplantation.
    Lab Invest, 91(8): 1158-69. [Abstract] [Full-text]
86. Role of combination of L-arginine and α-tocopherol in renal transplantation ischaemia/reperfusion injury: a randomized controlled experimental study in a rat model.
    BJU Int, 108(4): 612-8. [Abstract] [Full-text]
87. Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients.
    Arch Virol, 156(8): 1439-43. [Abstract] [Full-text]
88. Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation?
    BJU Int, 108(4): 590-4. [Abstract] [Full-text]
89. Donor hepatectomy for living donor liver transplantation: learning steps and surgical outcome.
    Dig Dis Sci, 56(8): 2482-90. [Abstract] [Full-text]

© 2004-2011 Organ Transplantation Research Today. All Rights Reserved.